Cypherpunk Technologies Inc.

$1.14

+$0.01 (+0.88%)

Jan 5, 2026

Price History (1Y)

Analysis

Cypherpunk Technologies Inc. is a Financial Services company within the Asset Management industry with 52 employees. The company has a market capitalization of $64.58 million. The company's financial health is characterized by significant losses and negative returns on equity and assets. Net income (TTM) was -$51,046,000, while EBITDA was -$47,558,248, and Free Cash Flow was -$32,071,624. The company has a cash balance of $9.69 million and debt of $38,000. Gross Margin, Operating Margin, and Profit Margin were all 0.0%. Return on Equity (ROE) was -196.8%, and Return on Assets (ROA) was -77.8%. The valuation context for Cypherpunk Technologies Inc. is characterized by negative metrics such as the EV/EBITDA ratio of -1.14. The Price to Book ratio was 17.54, but P/E Ratio (TTM) and Forward P/E were not available. Dividend Yield was also not available, and the Payout Ratio was 0.0%.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.

Visit website →

Key Statistics

Market Cap
$64.58M
P/E Ratio
N/A
52-Week High
$3.70
52-Week Low
$0.22
Avg Volume
25.28M
Beta
-0.19

Company Info

Exchange
NCM
Country
United States
Employees
52